Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview

AH Schinkel, JW Jonker - Advanced drug delivery reviews, 2012 - Elsevier
Active drug efflux transporters of the ATP binding cassette (ABC)-containing family of
proteins have a major impact on the pharmacological behavior of most of the drugs in use …

The pharmacology and clinical pharmacology of 3, 4-methylenedioxymethamphetamine (MDMA,“ecstasy”)

AR Green, AO Mechan, JM Elliott, E O'Shea… - Pharmacological …, 2003 - ASPET
The amphetamine derivative (±)-3, 4-methylenedioxymethamphetamine (MDMA, ecstasy) is
a popular recreational drug among young people, particularly those involved in the dance …

Blood–brain barrier dysfunction in parkinsonian midbrain in vivo

R Kortekaas, KL Leenders… - Annals of …, 2005 - Wiley Online Library
Parkinson's disease (PD) is associated with a loss of neurons from the midbrain. The cause
of PD is unknown, but it is established that certain neurotoxins can cause similar syndromes …

Role of drug efflux transporters in the brain for drug disposition and treatment of brain diseases

W Löscher, H Potschka - Progress in neurobiology, 2005 - Elsevier
The blood–brain barrier (BBB) serves as a protective mechanism for the brain by preventing
entry of potentially harmful substances from free access to the central nervous system …

A self-destructive nanosweeper that captures and clears amyloid β-peptides

Q Luo, YX Lin, PP Yang, Y Wang, GB Qi… - Nature …, 2018 - nature.com
Cerebral amyloid β-peptide (Aβ) accumulation resulting from an imbalance between Aβ
production and clearance is one of the most important causes in the formation of Alzheimer's …

The blood-brain and blood-tumor barriers: a review of strategies for increasing drug delivery

DR Groothuis - Neuro-oncology, 2000 - academic.oup.com
Drug delivery to brain tumors has been a controversial subject. Some believe the blood-
brain barrier is not important, while others believe it is the major obstacle in treatment and …

Demystifying brain penetration in central nervous system drug discovery: Miniperspective

L Di, H Rong, B Feng - Journal of medicinal chemistry, 2013 - ACS Publications
This Perspective provides important concepts about the blood–brain barrier (BBB) in drug
discovery and how they should be applied effectively in designing successful CNS drugs …

Impact of drug transporter studies on drug discovery and development

N Mizuno, T Niwa, Y Yotsumoto, Y Sugiyama - Pharmacological reviews, 2003 - ASPET
Drug transporters are expressed in many tissues such as the intestine, liver, kidney, and
brain, and play key roles in drug absorption, distribution, and excretion. The information on …

Multixenobiotic resistance as a cellular defense mechanism in aquatic organisms

SM Bard - Aquatic Toxicology, 2000 - Elsevier
Multixenobiotic resistance in aquatic organisms exposed to natural toxins or anthropogenic
contaminants is a phenomenon analogous to multidrug resistance in mammalian tumor cell …

The impact of P-glycoprotein on the disposition of drugs targeted for indications of the central nervous system: evaluation using the MDR1A/1B knockout mouse model

A Doran, RS Obach, BJ Smith, NA Hosea… - Drug Metabolism and …, 2005 - ASPET
Thirty-two structurally diverse drugs used for the treatment of various conditions of the
central nervous system (CNS), along with two active metabolites, and eight non-CNS drugs …